Latest News in the pharma Industry

Biopharma News

Proclara Biosciences Australia awarded grant to help develop new biotherapy with blockbuster potential

Proclara Biosciences Australia awarded grant to help develop new biotherapy with blockbuster potential

12 Mar 2017

Work on a second-generation fusion protein due to start in 2017 at Patheon's manufacturing facility in Brisbane.

Read more 
Horizon Discovery enters into R&D and licensing partnership for bioproduction cell line optimisation

Horizon Discovery enters into R&D and licensing partnership for bioproduction cell line optimisation

9 Mar 2017

Partnership formed to evaluate the impact of Amplycell’s novel cell fitness technology on expression capacity of Horizon’s bioproduction cell line.

Read more 
Apotex to invest $184 million to grow US manufacturing presence

Apotex to invest $184 million to grow US manufacturing presence

9 Mar 2017

Expansion plan comprises company's largest investment in the US.

Read more 
Sandoz proposed biosimilar adalimumab demonstrates equivalent efficacy as Humira

Sandoz proposed biosimilar adalimumab demonstrates equivalent efficacy as Humira

6 Mar 2017

Comprehensive development program show potential of GP2017 to treat inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.

Read more 
First ever biosimilar of interferon beta-1a approved in Russia

First ever biosimilar of interferon beta-1a approved in Russia

5 Mar 2017

Represents Biocad's third authorized medicine for the treatment of relapsing-remitting multiple sclerosis.

Read more 
Allergopharma opens new biopharmaceutical production in Reinbek

Allergopharma opens new biopharmaceutical production in Reinbek

4 Mar 2017

Merck's €42 million investment expands the allergies business on a global scale.

Read more 
Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

4 Mar 2017

MEDI8897 has been engineered to have a long half-life so that only one dose would be needed for the entire RSV season.

Read more 
Roquette commits to bioharma market with new products

Roquette commits to bioharma market with new products

2 Mar 2017

Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries.

Read more 
FDA accepts BLA for avelumab for the treatment of metastatic urothelial carcinoma for Priority Review

FDA accepts BLA for avelumab for the treatment of metastatic urothelial carcinoma for Priority Review

28 Feb 2017

Second Biologics License Application accepted by the FDA for avelumab.

Read more 
Sanofi and Lonza join hands to establish large-scale biologics production facility

Sanofi and Lonza join hands to establish large-scale biologics production facility

27 Feb 2017

Partnership leverages Lonza's expertise in large-scale mammalian cell culture facilities alongside Sanofi's strength in developing and launching biologics based treatments.

Read more 
Valeant's treatment for plaque psoriasis gets FDA thumbs up for Siliq

Valeant's treatment for plaque psoriasis gets FDA thumbs up for Siliq

16 Feb 2017

More than 50% of patients in three clinical studies who used Siliq achieved total skin clearance within a year.

Read more 
Austrian Centre of Industrial Biotechnology and GE Healthcare establish a cell line engineering collaboration

Austrian Centre of Industrial Biotechnology and GE Healthcare establish a cell line engineering collaboration

9 Feb 2017

Partnership to explore and identify new tools and methods to modify and optimize the CHO cell line performance.

Read more